Sex differences Decreased occlusal loading s u m m a r y Objective: Temporomandibular joint (TMJ) diseases predominantly afflict women, suggesting a role of estrogen in the disease etiology. Previously, we determined that decreased occlusal loading (DOL) inhibited collagen type II (Col2) expression in the mandibular condylar cartilage (MCC) of female wild-type (WT) mice whereas no change was observed in males. This decrease in chondrogenesis was abolished by estrogen receptor beta (ERb) deficiency in females. Therefore, the goal of this study was to examine the role of estradiol e ERb signaling in mediating DOL effects in male mice to further decipher sex differences. Methods: Male 21 day-old WT and ERbKO male mice were treated with either placebo or estradiol and exposed to normal or DOL for 4 weeks. Cartilage thickness and cell proliferation, gene expression and immunohistochemistry of chondrogenic markers and estrogen receptor alpha (ERa), and analysis of bone histomorphometry via microCT were completed to ascertain the effect of estradiol on DOL effects to the TMJ. Results: ERbKO male mice lack a MCC phenotype. In both genotypes, estradiol treatment increased Col2 gene expression and trabecular thickness. DOL in combination with estradiol treatment caused a significant increase in Col2 gene expression in both genotypes. Conclusions: The sex differences in DOL-induced inhibition of Col2 expression do not appear to be mediated by differences in estradiol levels between male and female mice. Greater understanding on the role of estrogen and altered loading are critical in order to decipher the sex dimorphism of TMJ disorders.
Introduction
Temporomandibular joint (TMJ) pain afflicts approximately 10% of the United States population with roughly half of this pain associated with joint degenerative disease (TMJ-DD) 1, 2 . It has been postulated that excessive TMJ remodeling in response to altered mechanical loading is a major factor in the development of TMJ-DD 3, 4 . Further, women who engage in increased oral parafunctional behavior are the population most subject to developing TMJ-DD 5e8 . These clinical statistics suggest the role of estrogen and mechanical loading-induced TMJ remodeling in the disease process.
Unlike most hyaline articular cartilages of the appendicular joints, the mandibular condylar cartilage (MCC) is derived from periosteal tissue and comprised of fibrocartilage 9, 10 . In response to altered loading, the MCC is known to regulate the size and properties of the tissue to adapt to the change in load 11e17 . This response is mediated by the osteochondral progenitor cells located within the proliferative zone of the cartilage 18e20 . These cells are typically quiescent and are activated to undergo proliferation. Afterwards, they either continue to proliferate or proceed through cell cycle arrest to then differentiate into chondrocytes which express collagen type II and aggrecan 18, 21 . This process is further regulated by estrogen signaling 22e24 which predominantly occurs through two receptor isoforms, estrogen receptor alpha (ERa) and beta (ERb) . Ligand binding of estrogen to either receptor induces a conformational change, receptor dimerization, nuclear translocation, and target gene transcription. Elucidating the combined role of altered loading and estradiol to the TMJ and deciphering sex differences that mediate these responses is vital for developing treatments to combat accelerated alterations to the joint.
In the TMJ, we have optimized a decreased occlusal loading (DOL) mouse model that consists of incisor trimming and soft diet administration 25 . Utilizing this model, we have observed a decrease in MCC thickness in both male and female mice in response to this underloading treatment 25e27 . Surprisingly, DOL reduced collagen type II (Col2) expression only in females, suggesting sex differences in the role estradiol plays in load altered load-induced MCC chondrogenesis 25, 26 . Estrogen-mediated sex differences have been previously observed in periosteal-derived tissue. Male and female mice deficient in ERa express a characteristic skeletal phenotype 28, 29 . In contrast, only female mice deficient in ERb display a unique skeletal phenotype 29e32 . In bone, female mice deficient in ERb experience an increase in mechanical loading-induced periosteal bone formation suggesting this receptor may inhibit altered load-induced remodeling 33 . However, the role of estradiol on the MCC of male mice in decreased loading conditions is unknown.
In the female MCC, we have previously determined that DOL inhibition of Col2 expression was abolished by ERb deficiency suggesting that estradiol inhibition of TMJ chondrogenesis in this altered loading state is mediated by ERb signaling 27 . Therefore, the major goal of this study was to examine whether the sex differences in DOL-induced inhibition of Col2 expression are controlled by an estradiol-ERb signaling pathway utilizing male mice. In order to examine this, 21 day-old male WT and ERbKO mice were treated with placebo or estradiol and exposed to either normal or DOL for 4 weeks. We hypothesized that estradiol treatment would result in a DOL-induced inhibition of Col2 expression in male WT mice but not ERbKO mice. As such, cartilage thickness, cell proliferation, gene expression of chondrogenic markers and estrogen receptors, and microCT analysis of bone architecture were completed. Determining a mechanism by which estradiol mediates altered loadinginduced TMJ remodeling is critical in order to decipher the sex dimorphism of the disease.
Materials and methods

Mice
All experiments were performed in accordance with animal welfare based on an approved Institutional Animal Care and Use Committee (IACUC) protocol (#AAAH9166) from Columbia University. Breeding pairs of C57BL/6 WT (Cat# 000664) and ERbKO mice (homozygous male, heterozygous female, Cat# 004745) were purchased from the Jackson Laboratory (Bar Harbor, ME, USA). Twenty-one day-old WT and ERbKO male mice were divided into four groups (n ¼ 12 for each group: n ¼ 6 for histology/microCT and n ¼ 6 for mRNA): placebo (Plb)/normal load (NL), placebo (Plb)/ DOL, estradiol (Esd)/NL, and estradiol (Esd)/DOL (Table I) . This age was chosen for two reasons: (1) eruption of molars and occlusion are complete at this age 34 (2) majority of MCC growth in mice is completed by 60 days of age 35 . Mice were administered placebo or 17b-estradiol (60 day release, Innovative Research of America, FL) for 28 days at a daily dose of 10 ng/g body weight. The dose of estradiol utilized in this study matches the dose found effective to restore MCC thickness in female, ovariectomized WT mice of the same age 36 . Half of the mice were subjected to DOL involving mandibular incisor trimming and a soft-dough diet (Transgenic Dough Diet; Bioserv, Frenchtown, NJ) as detailed previously 26 . The NL groups received a hard-dough diet. Following 4 weeks of treatment, mice were injected intraperitoneally with 0.1 mg bromodeoxyuridine (BrdU) per gram body weight at 3 and 19 h prior to euthanasia to track proliferating cells.
Histomorphometry and immunohistochemistry
Histomorphometry and immunohistochemistry techniques were employed to determine the effect of estradiol and DOL treatment on condylar cartilage cellular and matrix changes in male WT and ERbKO mice. Whole mouse heads were sectioned into halves, fixed in 10% formalin for 4 days at room temperature and decalcified in 14% ethylenediaminetetraacetic acid (EDTA) (pH 7.1) (Sigma, St. Louis, MO, USA) for 28 days. Subsequently, the samples were processed through progressive concentrations of ethanol, cleared in xylene, and embedded in paraffin. Sagittal serial sections of 5 mm thickness were made of the TMJ utilizing a Microm HM 355s microtome (Thermo Fisher Scientific, Waltham, MA, USA). Sections representing the mid-coronal portion of the mandibular head were stained with hematoxylin and eosin (H&E) and Safranin-O (SafO) and used as the representative central section for analysis.
Histomorphometry measurements were made in a blinded, nonbiased manner using the BioQuant computerized image analysis system (BioQuant, Nashville, TN, USA). MCC analysis was performed on H&E sagittal sections corresponding to the mid-coronal portion of the mandibular condylar head. Average thicknesses were determined for each region and summed for the total cartilage thickness. Condyles from six mice within each group were analyzed and the average of three-five sections was taken for each sample.
For immunohistochemistry, tissue sections were deparaffinized with xylene and rehydrated in progressive ethanol/water solutions with increasing concentrations of deionized water. Following rehydration, the sections were digested for 10 min with pepsin for unmasking (Lab Vision, Fremont, CA, USA), washed with PBS, and treated with a 3 vol% hydrogen peroxide in methanol solution to inhibit endogenous peroxidase activity. All sections were blocked with 10% normal goat serum (Life Technologies) to reduce nonspecific binding of the antigen with the primary antibody. Immunohistochemical staining was performed using the SuperPicture™ Polymer horseradish peroxidase (HRP) Broad Spectrum Detection Kit (Life Technologies) following the procedure recommended by the manufacturer. Collagen type II (Millipore; MAB8887, 1:100 dilution), ERa (Abcam; ab75635, 1:100 dilution) and androgen receptor (Abcam, ab74272, 1:100 dilution) primary antibodies were utilized in this study. After incubation with the primary antibodies (Col2: 60 min at RT; ERa and androgen receptor: overnight at 4 C), sections were washed twice in PBS. The secondary antibody e HRP conjugate (SuperPicture™, Life Technologies) was added and incubated for 10 min at RT. Following 2X PBS wash, sections were stained with DAB chromogen (30 mL DAB in 1 mL diluent, ImmPACT DAB, Vector Laboratories) for 2 min. Sections were then counterstained with either hematoxylin (Col2 staining) or 0.2% Fast Green (ERa and androgen receptor staining) for 30 s, dehydrated, and mounted. BrdU immunohistochemical analysis to determine proliferating cells was completed using a BrdU staining kit following the manufacturer's instructions (Zymed Laboratories-Invitrogen Corporation, Carlsbad, CA, USA). To quantify BrdU, the labeling index (number of BrdU positive cells divided by the total number of cells) was calculated. Three to six sections, corresponding to the same anatomical region utilized to determine total cell number (midcoronal), were counted for each group and the average index of these sections was used for the labeling index.
mRNA Extraction and PCR amplification
After duration of treatment, mRNA from the condylar cartilage of all groups was extracted to analyze the effects of estradiol and DOL on the expression of chondrocyte markers and ERa. For each mouse, the MCC (left and right) was carefully isolated from all other soft tissue and dissected under a dissecting microscope. mRNA was extracted with TRIzol Reagent (Ambion by Life Technologies) following the manufacturer's protocol and treated with DNase treatment and removal kit (Ambion by Life Technologies). Reverse transcription was performed to convert mRNA to cDNA utilizing the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA). Real-time polymerase chain reaction (RT-PCR) was conducted to assess the relative levels of genes of interest using the ViiA™ 7 Real-Time PCR System (Applied Biosystems, Life Technologies) following the protocol detailed in Chen et al. 37 . Expression of each gene of interest was determined relative to the Gapdh housekeeping gene (Gapdh e MM99999915_g1) utilizing the DDC T method. Gene expression was analyzed for the following chondrocyte markers: parathyroid hormone-related peptide (PTHrP e Mm00436057_m1), SRY-box containing gene 9 (Sox9 e MM00448840_m1), collagen type II (Col 2a1 e Mm00491889_m1), collagen type X (Col 10a1 e Mm00487041_m1), sclerostin (Sost e Mm00470479_m1), indian hedgehog (Ihh e Mm00439613_m1), estrogen receptor a (Esr1 e Mm00433149_m1), and estrogen receptor b (Esr2 e Mm00599819). All primers were purchased from Applied Biosystems.
Micro-CT analysis
The effect of estradiol and DOL on WT and ERbKO male mice subchondral bone architecture was accessed utilizing cone-beam micro-focus X-ray computed tomography (mCT40, Scanco Medical AG, Bassersdorf, Switzerland) as previously described 26 . Briefly, serial tomographic images from six mice per group were acquired at 55 kV and 145 mA and 2000 projections per rotation were collected at 300 ms integration time. Three-dimensional 16-bit grayscale images were reconstructed with standard convolution back-projection algorithms with Shepp and Logan filtering. Bone was segmented from marrow and surrounding soft tissue including cartilage using a constrained Gaussian filter to reduce noise at a threshold of 480 mg/cm 3 . Volumetric regions were selected to include the mandibular condyle. Bone volume fraction, trabecular number, trabecular thickness, and trabecular spacing were determined.
Statistical analysis
Data points, averages, and confidence intervals are presented in the scatter plots. For histomorphometry and BrdU analysis, each data point represents the average value for each mouse sample obtained from 3 to 6 histological sections. Confidence intervals were determined for the data sets using a t-distribution for sample sizes smaller than 30. T values were determined for a 95% confidence with degrees of freedom dependent on sample size (e.g., the value for 5 degrees of freedom for a sample size of six for a 95% confidence interval is 2.571). The standard deviation divided by the square root of the sample size was multiplied by the t value. This value was then added and subtracted from the sample means to determine the upper and lower bounds for the confidence interval. Normal distribution of the data was confirmed via the Shapiro-Wilk test using SPSS. Significant outliers were removed using Tukey's outlier method which was only necessary for the BrdU data. Specifically, the interquartile range was multiplied by 2.2 and subtracted from the lower quartile and added to the upper quartile. Observations were removed if they fell below or above these determined values. Statistical significance of differences among means was determined by a Student's t-test when comparing one factor (genotype, estradiol, or DOL alone) and twoway analysis of variance (ANOVA) with post hoc analysis by the Bonferonni method using SPSS when determining the combined effect of estradiol and DOL. The combined effects of estradiol and DOL were determined by significance between NL þ Esd vs DOL þ Esd and DOL þ Plb vs DOL þ Esd. Statistical significance was defined as P < 0.05 and the specific P values are denoted in the respective plots.
Results
Experimental groups and sample sizes utilized for this study are detailed in Table I . Estradiol treatment resulted in a significant decrease in body weight in both WT (WT Plb ¼ 21.8 ± 1.3 vs WT Esd ¼ 19.7 ± 1.6) and ERbKO (KO Plb ¼ 21.7 ± 1.4 vs KO Esd ¼ 19.2 ± 1.6) mice, an effect which has been shown previously 38 . However, DOL treatment had no significant effect on male mice body weight in either genotype.
ERbKO male mice do not exhibit a MCC or subchondral bone phenotype
There was no significant difference in cartilage morphology [ Fig. 1(A) and (B)] or cartilage thicknesses as determined by histomorphometry [ Fig. 1(C) ] between male WT and ERbKO mice. Gene expression and immunohistochemical staining of Col2 and bone morphology as determined by mCT also revealed no statistically significant differences comparing the WT and ERbKO mice ( Supplementary Fig. 1 ).
Estradiol treatment results in anabolic changes in the MCC and subchondral bone
Estradiol treatment did not result in any significant change in cartilage thickness in 49 day-old male WT and ERbKO mice 
Sex steroid levels in response to DOL and estradiol treatment
Estradiol treatment did not significantly affect ERa expression for either genotype. DOL resulted in a decrease in ERa expression in WT mice which was not changed when estradiol was administered as seen by immunohistochemistry [ Fig. 6(A) ] and gene expression analysis [ Fig. 6(B) ]. Neither DOL nor estradiol treatment significantly affected the gene expression of ERb in the WT groups as seen in Fig. 6(C) . However, estradiol treatment did increase the localization of androgen receptor in the MCC in the WT mice but not the ERbKO mice as shown in Supplementary Fig. 2 .
Discussion
The major goal of this work was to examine whether the sex differences in DOL-induced inhibition of chondrocyte maturation were mediated by an estradiol-ERb signaling pathway. Overall, two major findings resulted from this study. First, male mice lack an ERb mandibular condylar phenotype indicating estrogen-induced TMJ growth and remodeling are not directly mediated by ERb in male mice. Second, the sex differences in DOL-inhibition of chondrocyte maturation, specifically decreased Col2 gene expression and protein production seen in females but not males, are not mitigated by supraphysiological estradiol levels.
ERb has no significant effect on mandibular condylar phenotype or remodeling in male mice
In 49 day-old male mice, no statistically significant differences were observed in any cartilage or subchondral bone measurements of the WT mandibular condyle compared to ERbKO mice. In addition, we found no significant change in the response to DOL in placebo treated WT mice compared to placebo treated ERbKO mice. This is in contrast to 49 day-old female mice, in which we found that ERbKO mice exhibited increased cartilage thickness, increased chondrocyte maturation gene expression, and increased total volume in the subchondral bone compared to age-matched WT controls 36 . We also found that DOL-induced inhibition of Col2 expression that occurs in WT female mice did not occur in female ERbKO mice 27 . These combined results are consistent with previous findings that illustrate an ERb phenotype solely in the cortical bone, trabecular bone, and growth plate cartilage of female mice 29, 32, 39 . These results highlight the fundamental differences in the role of ERb in mediating TMJ growth and remodeling in males vs females.
Effects of estradiol on the mandibular condyle in male mice
Multiple studies have illustrated the effect of estradiol on MCC metabolism in females 22,23,40e42 . However, the role of estradiol supplementation in male mice is unclear. Estradiol treatment resulted in differential effects to the MCC thickness and proliferation in male mice compared to effects previously observed in female mice. In females, it has been shown that estrogen treatment causes a decrease in MCC thickness in ovariectomized WT mice but not in ERbKO mice 23, 37 . Further, ovariectomy results in increased proliferation in female WT but not ERbKO mice 37, 42 . In this study, we found that estrogen treatment did not significantly affect the MCC thickness or proliferation in male WT or ERbKO mice. One reason for the observed sex differences may be that estradiol treatment was conducted in gonad-intact mice in this study, whereas estradiol treatment was performed in ovariectomized female mice in our previous studies. However, Figueroba et al. showed that estradiol treatment in gonadectomized male rats did not drastically effect MCC thickness compared to the changes observed in female rats supporting the findings from this study 43 . Therefore taken together, the results suggest that estrogen via ERb inhibits proliferation and subsequent thinning of the MCC in female but not in male WT mice.
On the other hand, estradiol treatment promoted chondrogenesis in male mice. In this study, we found that similar to female mice, estradiol caused a significant increase in Col2 gene expression and protein production in both genotypes 37 . Estradiol is known to For histomorphometric and BrdU analysis, n ¼ 6 mice were utilized for all groups and the average of 3e6 sections/mouse was analyzed. BrdU þ cells were normalized to the total number of cells in the cartilage region as determined from the adjacent H&E section. Statistical significance was determined by a two-way ANOVA followed by posthoc analysis with the Bonferonni method with P < 0.05. Exact P values are listed above the bars that denote significance. promote chondrogenesis in hyaline cartilage and delay experimental arthritis 44 , emphasizing the anabolic effects of estrogen observed in this study 45 . Specifically in males, estradiol has been shown to increase bone mineral density and exhibit a bone sparing effect 46e49 and promote epiphyseal closure 50 . These results strongly suggest that estrogen promotes TMJ chondrogenesis independent of ERb in both sexes.
While a few studies have looked at the role of estrogen in mediating the microarchitecture of the mandibular condylar subchondral bone in females, not much is known in male mice. In this study, we found that estrogen caused an increase in trabecular thickness independent of ERb. In females, estrogen deficiency induced bone loss as measured by trabecular thickness and bone volume fraction in the mandibular subchondral bone of female rats 51 . Further, studies investigating the role of genistein, a phytoestrogen that structurally resembles 17b-estradiol, illustrated an increase in trabecular thickness and bone volume fraction dependent on ERb in female rats 52 . Thus, estradiol promotes anabolic changes in the mandibular condylar subchondral bone of both sexes; however, the increase in trabecular thickness may only depend on ERb in females.
Sex differences in the effects of estradiol and DOL on the TMJ
We previously found that DOL caused inhibition of Sox9 and Col2 expression in female mice only 26 and these effects were abolished by ERb deficiency 27 . Thus, we hypothesized that estradiol treatment to DOL male mice would cause inhibition of Col2 expression in WT but not in ERbKO mice. However, we observed the opposite effect. Estradiol treatment with DOL resulted in an increase in Col2 and Sox9 expression and a decrease in Sost expression in both genotypes. These results suggest that the sex differences in response to DOL are not mediated by differences in estradiol levels between male and female mice.
Sex differences in the estrogen receptor expression levels and/or the role of these receptors in mediating mechanical loadinginduced TMJ remodeling may exist. For example, in the rat condylar cartilage, the number of cells expressing ERa and ERb were significantly larger in males compared to females from through 12 months 53 . It has previously been shown that estrogen deficiency alone or in combination with decreased loading increases ERa expression in female rats 40 . While we did observe a decrease in ERa expression with DOL in WT male mice in this study, no significant change was observed with estradiol or the combined treatments. Thus, the significant increase in Col2 expression in response to estradiol treatment and DOL is not directly dependent on ERa expression levels in male mice.
Further, it is probable that estradiol treatment may affect TMJ growth and remodeling differently in males and females resulting in differential responses to altered mechanical loading. Estradiol inhibits proliferation solely in female mice which may result in fewer cells available for chondrogenesis compared to male mice that are exposed to DOL. In support, it has previously been shown that ovariectomized female rats exposed to a soft diet exhibited an increased Col2 area compared to non-ovariectomized female rats exposed to a soft diet suggesting that estradiol and decreased loading reduce the number of cells undergoing chondrogenesis 41 . Also, sex differences in cell proliferation in response to strain have been shown in murine osteoblasts 54 . Collectively, these results suggest the male MCC exhibits an increased estrogen-mediated adaptive capacity to resist altered mechanical loading.
A working model illustrating the effects of estradiol and DOL in the MCC is provided in Fig. 7 . We posit that DOL causes cell cycle arrest in both sexes. However, we propose that DOL and/or estradiol via ERb inhibits TMJ progenitor cell activation solely in female mice. Therefore, when estradiol and DOL treatment are combined in the male mice, we propose that DOL results in an increase in the number of cells undergoing cycle arrest and primed for chondrogenic differentiation, which is then promoted by estradiol. This results in the increase in Col2 expression and one possible mechanism for the partial increase in cartilage thickness compared to DOL alone. In contrast, ERb causes a decrease in the number of activated progenitor cells in female mice, thereby causing a decrease in the number of cells available for chondrogenesis. These sex differences related to MCC chondrogenesis provide one mechanism to explain the discrepancies in TMJ disorders between males and females.
We recognize that our study has many limitations. First, the mice utilized in this study were young, growing 49-day old mice. Thus, any changes observed cannot be directly translated to effects that may occur in older mice. Also, the aim of this study was to determine if supraphysiological estradiol levels in male mice resulted in similar results compared to the female studies. Naturally, circulating estradiol levels in male mice are negligible 55 . However, aromatization of testosterone is a common way in which males produce estrogen suggesting that estradiol levels may have been fluctuating throughout the experiment 39, 56 . Also, the supraphysiological levels of estrogen administered to male mice in this study may be suppressing androgen levels and causing the observed effects 57 . Supplementary Fig. 2 illustrates an increase in androgen receptor staining solely in WT mice after estradiol treatment possibly indicating a change in androgen levels in these mice. Lastly, this study was conducted using global ERbKO mice that may express ERb splice variants. Thus, future studies using conditional ERbKO mice with complete deletions of ERb in specific cell populations will be advantageous in ascertaining the local effects of estradiol and DOL.
In conclusion, this study illustrates that estradiol treatment independent of ERb results in an increase in chondrogenesis in the male MCC. Further, estradiol treatment administered with DOL causes enhanced chondrogenesis in male mice independent of ERb. Taken together, these results suggest that there are sex differences in response to DOL and estradiol in the TMJ. Thus, additional investigation of the role of estradiol signaling in both males and females is necessary to gain greater understanding of the sexual dimorphism in TMJ disorders and develop sex-specific regeneration strategies. 
